|Articles|May 1, 2020
- Pharmaceutical Executive-05-01-2020
- Volume 40
- Issue 5
Pharmaceutical Executive, May 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec's Emerging Pharma Leaders 2020over 6 years ago
AI: Kickstarting the Race Against COVID-19over 6 years ago
Competition for Biotech CFOs is Heating Upover 6 years ago
Biopharma Sustainability Considered Essentialover 6 years ago
CFOs Outlook: Forging a Sustainable Futureover 6 years ago
Drive for COVID-19 Therapies Raises Patent and Pricing Issuesover 6 years ago
Biotech in the Age of COVID: The Pain and the Gainover 6 years ago
A New, Less Friendly Normal Looms for European Drugmakersover 6 years ago
How Prepared Were Doctors for the COVID Digital Upswing?over 6 years ago
Pharmaceutical Executive, May 2020 Issue (PDF)Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
5